Covaxin may get WHO approval by month-end, says NITI Aayog


New Delhi, Sep 15 (IANS): India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients to travel abroad without mandatory quarantine, NITI Aayog's Member, Health, V.K. Paul said on Wednesday.

Data sharing and data evaluation are going on and a positive decision may come soon, he said.

"The data sharing and data evaluation have been going on through multiple reviews and we are close to a decision point.

"We must give time to WHO to make their decisions based on science. However, we hope that these decisions can be taken quickly because people who are receiving Covaxin have certain imperatives of travel. Most of us, who chose the concurrency, is important in terms of licensure. We are hoping for an early decision," Dr Paul said.

"We believe that a positive decision could be coming in, before the end of the month," he added.

In August, Indian Health Minister Mansukh Mandaviya also met WHO Chief Scientist Dr Soumya Swaminathan and held discussions over the WHO approval of Covaxin.

The vaccine's developer Bharat Biotech has submitted its Phase 3 clinical trials data that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

The WHO has so far approved Covid-19 vaccines by Pfizer-BioNTech, AstraZeneca, Johnson and Johnson, Moderna, and Sinopharm.

 

  

Top Stories

Comment on this article

  • Monty Dotor, Mangalore

    Thu, Sep 16 2021

    PM has taken Covaxin, so it will get approval from WHO before his trip abroad.

    DisAgree Agree [6] Reply Report Abuse

  • Jossey Saldanha, Thane

    Thu, Sep 16 2021

    Covishield is better than Covaxin ...

    DisAgree [6] Agree Reply Report Abuse

  • Alva, Mangalore

    Thu, Sep 16 2021

    Your mindset is such that If we export gau mootra to US and then import back with US packaging, then that becomes better for you.

    DisAgree Agree [2] Reply Report Abuse

  • Mangalurian, Mangaluru

    Thu, Sep 16 2021

    Counting the chickens before they hatch? There's many a slip between the cup and the lip! India is world famous for cheating and fraud. What is needed is for India to have greater discipline and credible research. Once the world starts starts noticing some serious research coming from India, the world will automatically start recognising Indian products. Regardless, what does NITI Aayog have anything to do with the products of a private company? If anything, NITI Aayog must focus on credible statistics.

    DisAgree [4] Agree [4] Reply Report Abuse

  • j.anata, Mangaluru / Bengaluru

    Thu, Sep 16 2021

    Keep speaking ill of your country

    DisAgree [1] Agree [1] Reply Report Abuse


Leave a Comment

Title: Covaxin may get WHO approval by month-end, says NITI Aayog



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.


Security Validation

Enter the characters in the image